Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ DLL3 Recombinant Human Monoclonal Antibody (7B7)

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA543156

Catalog No. PIMA543156


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Antibody tested in Indirect ELISA.

Delta-like protein 3 (DLL3) is a ligand for the Notch signaling pathway. It inhibits primary neurogenesis. DLL3 plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. Defects in DLL3 are the cause of Spondylocostal dysostosis autosomal recessive type 1 (SCDO1). Mutations in DLL3 gene cause truncal shortening relative to their limbs, which leads to abdominal protrusion, abnormal spinal curvature and sometimes a plagiocephaly-torticollis sequence. It may be required to divert neurons along a specific differentiation pathway.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

DLL3
Recombinant Monoclonal
1 mg/mL
PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4
Q9NYJ7
Dll3
Recombinant Human DLL3 protein.
100 μL
Primary
Human
Antibody
IgG1
ELISA, Flow Cytometry
7B7
Unconjugated
Dll3
delta like canonical Notch ligand 3; Delta3; delta-like 3; delta-like 3 (Drosophila); delta-like protein 3; Dll3; Drosophila Delta homolog 3; M-Delta-3; pu; pudgy; SCDO1
Human
Affinity Chromatography
RUO
10683
-20°C or -80°C if preferred
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.